Kim H, Kim T
Biomolecules. 2024; 14(2).
PMID: 38397479
PMC: 10887045.
DOI: 10.3390/biom14020242.
Persico T, Tranquillo M, Seracchioli R, Zuccarello D, Sorrentino U
Genes (Basel). 2024; 15(1).
PMID: 38275588
PMC: 10815814.
DOI: 10.3390/genes15010006.
Talvio K, Castren M
Front Cell Neurosci. 2024; 17:1322541.
PMID: 38259499
PMC: 10800791.
DOI: 10.3389/fncel.2023.1322541.
Santulli P, Blockeel C, Bourdon M, Coticchio G, Campbell A, De Vos M
Hum Reprod Open. 2023; 2023(2):hoad012.
PMID: 37124950
PMC: 10130191.
DOI: 10.1093/hropen/hoad012.
Sun B, Yeh J
Fertil Res Pract. 2021; 7(1):13.
PMID: 34193292
PMC: 8244159.
DOI: 10.1186/s40738-021-00105-7.
Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).
Ishizuka B
Front Endocrinol (Lausanne). 2021; 12:626924.
PMID: 33716979
PMC: 7949002.
DOI: 10.3389/fendo.2021.626924.
Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked Gene.
Napoli E, McLennan Y, Schneider A, Tassone F, Hagerman R, Giulivi C
Front Mol Biosci. 2020; 7:578640.
PMID: 33195422
PMC: 7642626.
DOI: 10.3389/fmolb.2020.578640.
Delayed and Precocious Puberty: Genetic Underpinnings and Treatments.
Gohil A, Eugster E
Endocrinol Metab Clin North Am. 2020; 49(4):741-757.
PMID: 33153677
PMC: 7705597.
DOI: 10.1016/j.ecl.2020.08.002.
Are ovarian response and pregnancy rates similar in selected FMR1 premutated and mutated patients undergoing preimplantation genetic testing?.
Ranisavljevic N, Hess M, Castelli C, Willems M, Ferrieres-Hoa A, Girardet A
J Assist Reprod Genet. 2020; 37(7):1675-1683.
PMID: 32483686
PMC: 7376994.
DOI: 10.1007/s10815-020-01809-3.
Health knowledge of women with a fragile X premutation: Improving understanding with targeted educational material.
Smolich L, Charen K, Sherman S
J Genet Couns. 2020; 29(6):983-991.
PMID: 31999047
PMC: 7390709.
DOI: 10.1002/jgc4.1222.
Fragile X-Associated Diminished Ovarian Reserve and Primary Ovarian Insufficiency from Molecular Mechanisms to Clinical Manifestations.
Man L, Lekovich J, Rosenwaks Z, Gerhardt J
Front Mol Neurosci. 2017; 10:290.
PMID: 28955201
PMC: 5600956.
DOI: 10.3389/fnmol.2017.00290.
Study of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 Gene.
Barasoain M, Barrenetxea G, Huerta I, Telez M, Criado B, Arrieta I
Genes (Basel). 2016; 7(12).
PMID: 27983607
PMC: 5192499.
DOI: 10.3390/genes7120123.
Endocrine Dysfunction in Female FMR1 Premutation Carriers: Characteristics and Association with Ill Health.
Campbell S, Eley S, McKechanie A, Stanfield A
Genes (Basel). 2016; 7(11).
PMID: 27869718
PMC: 5126787.
DOI: 10.3390/genes7110101.
Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions.
Zwemer L, Nolin S, Okamoto P, Eisenberg M, Wick H, Bianchi D
Prenat Diagn. 2016; 37(1):43-52.
PMID: 27646161
PMC: 5243172.
DOI: 10.1002/pd.4928.
Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series.
Debrey S, Leehey M, Klepitskaya O, Filley C, Shah R, Kluger B
Cerebellum. 2016; 15(5):623-31.
PMID: 27372099
DOI: 10.1007/s12311-016-0809-6.
FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.
Santa Maria L, Aliaga S, Faundes V, Morales P, Pugin A, Curotto B
Genet Res (Camb). 2016; 98:e11.
PMID: 27350105
PMC: 6865162.
DOI: 10.1017/S0016672316000082.
Genetic Counseling for Fragile X Syndrome: Recommendations of the National Society of Genetic Counselors.
McIntosh N, Gane L, McConkie-Rosell A, Bennett R
J Genet Couns. 2015; 9(4):303-25.
PMID: 26141473
DOI: 10.1023/A:1009454112907.
Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study.
Allen E, Grus W, Narayan S, Espinel W, Sherman S
Front Genet. 2014; 5:260.
PMID: 25147555
PMC: 4124461.
DOI: 10.3389/fgene.2014.00260.
Genes and genetic testing in hereditary ataxias.
Sandford E, Burmeister M
Genes (Basel). 2014; 5(3):586-603.
PMID: 25055202
PMC: 4198919.
DOI: 10.3390/genes5030586.
CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.
Ludwig A, Espinal G, Pretto D, Jamal A, Arque G, Tassone F
Hum Mol Genet. 2014; 23(12):3228-38.
PMID: 24463622
PMC: 4030777.
DOI: 10.1093/hmg/ddu032.